- Home
- TNGX vs RZLT Comparison
TNGX vs RZLT Comparison
Compare TNGX & RZLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNGX
- RZLT
- Stock Information
- Founded
- TNGX 2014
- RZLT 2010
- Country
- TNGX United States
- RZLT United States
- Employees
- TNGX N/A
- RZLT N/A
- Industry
- TNGX Biotechnology: Pharmaceutical Preparations
- RZLT Biotechnology: Pharmaceutical Preparations
- Sector
- TNGX Health Care
- RZLT Health Care
- Exchange
- TNGX Nasdaq
- RZLT Nasdaq
- Market Cap
- TNGX 723.2M
- RZLT 626.4M
- IPO Year
- TNGX N/A
- RZLT N/A
- Fundamental
- Price
- TNGX $7.35
- RZLT $7.72
- Analyst Decision
- TNGX Strong Buy
- RZLT Strong Buy
- Analyst Count
- TNGX 6
- RZLT 5
- Target Price
- TNGX $10.00
- RZLT $12.50
- AVG Volume (30 Days)
- TNGX 1.5M
- RZLT 888.9K
- Earning Date
- TNGX 11-05-2025
- RZLT 11-06-2025
- Dividend Yield
- TNGX N/A
- RZLT N/A
- EPS Growth
- TNGX N/A
- RZLT N/A
- EPS
- TNGX N/A
- RZLT N/A
- Revenue
- TNGX $24,296,000.00
- RZLT N/A
- Revenue This Year
- TNGX $20.42
- RZLT N/A
- Revenue Next Year
- TNGX N/A
- RZLT N/A
- P/E Ratio
- TNGX N/A
- RZLT N/A
- Revenue Growth
- TNGX N/A
- RZLT N/A
- 52 Week Low
- TNGX $1.03
- RZLT $2.22
- 52 Week High
- TNGX $10.81
- RZLT $8.34
- Technical
- Relative Strength Index (RSI)
- TNGX 60.63
- RZLT 64.42
- Support Level
- TNGX $6.38
- RZLT $7.23
- Resistance Level
- TNGX $6.90
- RZLT $8.34
- Average True Range (ATR)
- TNGX 0.44
- RZLT 0.36
- MACD
- TNGX 0.00
- RZLT -0.04
- Stochastic Oscillator
- TNGX 94.14
- RZLT 56.54
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.
About RZLT Rezolute Inc. (NV)
Rezolute Inc is a biopharmaceutical company. The company develops novel, sustained-release injectable therapies. It applies proprietary formulation and manufacturing capabilities to known, well-characterized molecules to create differentiated, patent-protected therapies that have the potential to significantly improve existing standards of care. Its pipeline products include RZ358 and RZ402.